Key result
Simple integer risk score stratifies hypertension and CAD patients, identifying a high-risk tier reaching ~18%.
Why the study?
It is difficult to accurately determine prognosis of patients with hypertension and chronic stable coronary artery disease.
Can a simple integer risk score accurately predict adverse cardiovascular events in patients with hypertension and chronic stable CAD?
Cohort (n=20,538)
Yes
Can a simple integer risk score accurately predict adverse cardiovascular events in patients with hypertension and chronic stable CAD?
A simple integer risk score using readily available clinical variables can accurately stratify patients with hypertension and chronic stable CAD into low, intermediate, and high-risk categories for adverse cardiovascular events.
May aid prognostication in hypertensive stable CAD patients; leaves open external validation before clinical adoption.
BACKGROUND: It is difficult to accurately determine prognosis of patients with hypertension and chronic stable coronary artery disease (CAD). Our aim was to construct a risk score for predicting important adverse events in this population. METHODS AND RESULTS: Patients with hypertension and chronic stable CAD enrolled in the INternational VErapamil-SR/Trandolapril STudy (INVEST) comprised the study cohort. Candidate predictor variables were obtained from patients with at least 1 postbaseline visit. Patients were divided into development (n=18 484) and validation cohorts (n=2054). Cox regression model identified predictors of the primary outcome: all-cause mortality, myocardial infarction, or stroke at a mean follow-up of 2.3 years. The hazard ratio of each variable was rounded to the nearest integer to construct score weights. A score 0 to 4 defined low-risk, 5 to 6 intermediate-risk and ≥7 high-risk. The following variables were retained in the final model: age, residence, body mass index, on-treatment heart rate and BP, prior myocardial infarction, heart failure, stroke/transient ischemic attack, smoking, diabetes, peripheral arterial disease, and chronic kidney disease. The primary outcome occurred in 2.9% of the low-risk group, 6.5% of the intermediate-risk group, and 18.0% of the high-risk group (P for trend <0.0001). The model was good at discriminating those who had an event versus those who did not (C-statistic=0.75). The model performed well in a validation cohort (C-statistic=0.77). CONCLUSION: Readily available clinical variables can rapidly stratify patients with hypertension and chronic stable CAD into useful risk categories.
No takes yet. Share an insight, caveat, or question.
Bavry et al. (2013) conducted a cohort in Hypertension and chronic stable coronary artery disease (n=20,538). Integer Risk Score vs. Low-risk vs intermediate-risk vs high-risk categories was evaluated on All-cause mortality, myocardial infarction, or stroke (p=<0.0001). A simple integer risk score successfully stratified patients with hypertension and CAD into low (2.9%), intermediate (6.5%), and high-risk (18.0%) categories for adverse events (P for trend <0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: